Shengda Biotech (603079): The tight upward trend in biotin supply and demand is expected to continue
Shengda Biotin (603079): Biotin prices are expected to be at the bottom and full-year performance is expected to grow rapidly
Shengda Biotech (603079): Biotin prices are expected to be at the bottom, and folic acid prices have risen
Shengda Biotech (603079): Biotin and folic acid prices are bottoming up, and the bio-preservative business is growing rapidly
Shengda Biotech (603079) covers for the first time: the world's largest supplier of biotin
Shengda Biotech (603079) IPO Research Report: The World's Largest Biotin Supplier
No Data